For life science companies pursuing a global strategy, funding is not a major bottleneck. Access to talent and a wider market play have emerged as key growth drivers for regional players.
At a life science-focused panel discussion – Building global life science champions from Singapore hub– at Asia PE-VC Summit 2021, Esco Lifesciences Group CEO XQ Lin and co-founder and CEO Lihan Zhou spoke about the challenges and opportunities as they draw up global expansion plans.
